About D-NOME
D-NOME is a company based in Hyderabad (India) founded in 2021 by Sujoy Deb and Divya Sriram. D-NOME has raised $1.56 million across 3 funding rounds from investors including LetsVenture, Ankur Capital and Campus Fund. The company has 1 employees as of April 07, 2024. D-NOME offers products and services including Diagnostics Platform. D-NOME operates in a competitive market with competitors including ArcherDX, Sino Biological, GenScript, OncoDNA and Fluent BioSciences, among others.
- Headquarter Hyderabad, India
- Employees 1 as on 07 Apr, 2024
- Founders Sujoy Deb, Divya Sriram
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name D-Nome Private Limited
- Date of Incorporation 20 Jul, 2021
- Jurisdiction Serilingampally, Telangana, India
-
Annual Revenue
$13.49 K (USD)-49as on Mar 31, 2023
-
Net Profit
-$48.27 K (USD)-1482.18as on Mar 31, 2023
-
EBITDA
-$44.06 K (USD)-113.17as on Mar 31, 2023
-
Total Equity Funding
$1.56 M (USD)
in 3 rounds
-
Latest Funding Round
$1.5 M (USD), Seed
Dec 23, 2022
-
Investors
LetsVenture
& 13 more
-
Employee Count
1
as on Apr 07, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of D-NOME
D-NOME offers a comprehensive portfolio of products and services, including Diagnostics Platform.
Enables rapid and accurate molecular diagnostics using synthetic tech.
Funding Insights of D-NOME
D-NOME has successfully raised a total of $1.56M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $1.5 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in D-NOME
D-NOME has secured backing from 14 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include LetsVenture, Ankur Capital and Campus Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments in digital, climate, and deep science technologies.
|
Locked | Locked | Locked | |
|
Student-led startups are invested in by this venture capital firm.
|
Locked | Locked | Locked | |
|
Venture capital firm investing in multiple sectors
|
Locked | Locked | Locked |
Investor details for D-NOME
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by D-NOME
Investment portfolio details for D-NOME
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - D-NOME
Detailed financials for D-NOME
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
D-Nome Comparisons
Peer comparison for D-NOME
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of D-NOME
D-NOME operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ArcherDX, Sino Biological, GenScript, OncoDNA and Fluent BioSciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Genomic and theranostic services for oncology precision medicine are delivered.
|
|
| Locked | Locked | Locked |
Proprietary reagents for single-cell genetic analysis are developed.
|
|
| Locked | Locked | Locked |
Speech recognition solutions are provided by Inscripta for healthcare professionals.
|
Detailed competitors of D-NOME
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on D-Nome
Complete news archive for D-NOME
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about D-NOME
D-NOME was founded in 2021.
D-NOME is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
D-NOME is a funded company, having raised a total of $1.56M across 3 funding rounds to date.
As of Apr 07, 2024, the latest employee count at D-NOME is 1.
Annual revenue of D-NOME is $13.49K as on Mar 31, 2023.
Developer of reagents and kits for molecular diagnostics. The company develops diagnostic reagents based on proprietary, innovative reagent technologies for genomic applications. The product line includes D-LAMP PCR enzyme mix and D-LAMP genome sequencing reagent.
D-NOME's top competitors include Sino Biological, OncoDNA and ArcherDX.
D-NOME offers Diagnostics Platform.
D-NOME has 14 investors. Key investors include LetsVenture, Ankur Capital, Campus Fund, 8X Ventures, and LV Angel Fund.
The valuation of D-NOME is $6.15M as of Dec 2022.